Single-Arm, Phase Ii Study To Evaluate The Safety And Efficacy Of Sacituzumab Govitecan In Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed On Second Generation Ar-Directed Therapy
JOURNAL OF CLINICAL ONCOLOGY（2020）
摘要
TPS251Background: In patients with mCRPC, androgen receptor (AR) pathway inhibitors such as enzalutamide or abiraterone acetate are often used as first-line systemic therapy. After progression on e...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要